Clinical trial
Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics
NCT02743273 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- November 30, 2017
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.